Summary
We have studied the effect of indobufen, a cyclo-oxygenase blocking agent which has proved useful in patients with obstructive vascular disease, on red blood cell (RBC) filterability in vitro and in a pilot study ex vivo.
The addition of indobufen in vitro to blood samples from 10 healthy volunteers did not significantly modify RBC deformability.
We evaluated the ex vivo effect of indobufen (200 mg bd) in 14 patients with obstructive vascular disease. A significant improvement in RBC deformability was noted on the 5th, 14th, and 28th days of treatment, 2 h after the morning dose. Acetylsalicylic acid given to 6 similar patients had no effect suggesting that the positive haemorheological effect of indobufen is probably not linked to its cyclooxygenase blocking effect.
References
Editorial (1978) Red cell deformability. Lancet 2: 1348–1349
Muller R (1980) Zum gegenwärtigen Stand der Hämorheologie aus klinisch-pharmakologischer Sicht. Therapiewoche 30: 2440–2451
Palinski W, Torsellini A, Doni L (1983) Influence of platelet activation on erythrocyte deformability. Thromb Haemostas 49: 84–86
Reid HL, Dormandy JA, Barnes AJ, Locke PJ, Dormandy TL (1976) Impaired red cell deformability in peripheral vascular disease. Lancet 1: 666–667
Schmid-Schöbein H, Volger E (1976) Red cell aggregation and red cell deformability in diabetes. Diabetes 25 [Suppl 2]: 897–902
Dodds AJ, O'Reilly MJG, Yates CJP, Cotton LT, Flute PT, Dormandy JA (1979) Haemorheological response to plasma exchange in Raynaud's syndrome. Br Med J 2: 1186
Horne McDK (1981) Sickle cell anemia as a rheological disease. Am J Med 70: 288–298
Saruta S (1981) Blood filterability in cerebrovascular disorders with special reference to erythrocyte deformability. Stroke 126: 824–828
Gresele P, Guerciolini R, Nenci GG (1982) Erythrocyte deformability changes in normal pregnancy and preeclampsia. Br J Haematol 52: 340–342
Dodds AJ, Boyd MJ, Allen J, Bennet CD, Flute PT, Dormandy JA (1980) Changes in red cell deformability and other haemorheological variables following myocardial infarction. Br Heart J 44: 508–511
Ono S, Ashida S, Abiko Y (1981) Haemorheological effect of ticlopidine in rats. Thromb Haemostas 46: 176
Sowemimo-Coker SO, Kovacs IB, Pickles H, Hedges A, Turner P (1983) Dipyridamole increases red cell deformability. Br J Clin Pharmacol 16: 423–425
Guerciolini R, Merante F, Gresele P, Grasselli S, Susani L, Nenci GG (1986) Effect of different plasma expanders on erythrocyte filterability. Clin Haemorheol 6: 511–521
Italian Multicenter Study Group (1985) Long-term antiplatelet activity and safety of indobufen in patients with cardiovascular disease. Intern J Clin Pharmacol Ther Toxicol 8: 439–446
Reid HL, Barnes AJ, Lock PJ, Dormandy JA, Dormandy TL (1976) A simple method for measuring erythrocyte deformability. J Clin Pathol 29: 855–859
Schafer AI, Handin RI (1979) The role of platelets in thrombotic and vascular disease. Progr Cardiovasc Dis 22: 31–52
Ulutin ON, Ozer M, Sari H, Akcam B, Ozdacaci T, Urgancioglu I, Balkuv-Ulutin S (1982) The effect of indobufen on the peripheric obliterative vascular diseases. Haemostasis 12: 181
Tamassia V, Corvi G, Fuccella LM, Moro E, Tosolini G, Tremoli E (1979) Indobufen (K 3920), a new inhibitor of platelet aggregation: Effect of food on bioavailability, pharmacokinetic and pharmacodynamic study during repeated oral administration to man. Eur J Clin Pharmacol 15: 329–333
Vittoria A, Laghi Pasini E, Messa GL, Di Perri T, Corvi G, Fuccella LM (1981) Inhibition of platelet aggregation in man by indobufen (K 3920). Int Med Res 9: 12
Pfafferott C, Meiselman HJ, Mochstein P (1982) The effect of malonyldialdehyde on erythrocyte deformability. Blood 59: 12–15
Dowd PM, Kovacs IB, Bland CJH, Kirby JDT (1981) Effect of prostaglandins I2 and E1 on red cell deformability in patients with Raynaud's phenomenon and systemic sclerosis. Br Med J 283: 350
Kovack IB, O'Grady J (1984) Prostacyclin increases filterability on normal and rigidified human red blood cells in vitro. Agent Action 14: 306–310
Slott JH, Hall K, Clark DA, Stuart MJ (1982) Prostaglandin I2 fails to influence red cell deformability. Prostaglandins Leukotrienes Med 8: 21
Belch JJF, Lowe GDO, Drummond MM, Forbes CD, Prentice CRM (1981) Prostacyclin reduces red cell deformability. Thromb Haemost 45: 189
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Grasselli, S., Guerciolini, R., Iadevaia, V. et al. In vitro and ex vivo effects of indobufen on red blood cell deformability. Eur J Clin Pharmacol 32, 207–210 (1987). https://doi.org/10.1007/BF00542198
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00542198